IN PATIENTS RECEIVING COVID19 TREATMENT; IS THERE A RELATIONSHIP BETWEEN DYSPNEA SEVERITY AND DEPRESSION AND ANXIETY SYMPTOMS?

From December 2019 to the present, the Coronavirus disease (COVID-19) has spread rapidly and turned into a pandemic. The virus first begins to spread between people during close contact, usually through tiny droplets produced by behavior such as sneezing, talking or coughing. COVID-19 disease can affect many organs and cause psychiatric disorders in patients. It is thought that anxiety and depression may continue in patients diagnosed and treated with COVID-19. The aim of our study is to investigate the prevalence of anxiety and depression in patients hospitalized due to COVID-19 in the long term (3-6 months), taking into account factors such as individuals' education level, occupation, alcohol use, smoking, loss of work force due to covid. At the same time, we planned to examine the interaction between dyspnea severity and anxiety and depression using the Medical Research Council Scale (MRCS) and the Hospital Anxiety and Depression Scale (HADS) in patients with continued exertional dyspnea in the post-covid period. The study was completed with 537 patients. 307 (57%) of the patients were male, 230 (42%) were female. No significant difference was determined in terms of mean age. No patient was excluded from the study for any reason. And accordingly, it would be appropriate to keep risky groups under observation, to provide necessary psychological support in the early period, and to follow them closely.